AGO2 and fatty liver disease: We also posit that there may be important translational implications for our findings, especially in the design of therapeutic interventions, to target modulation of a spectrum of Ago2-dependent miRNA-mediated events, in chronic metabolic disorders, such as diabetes, fatty liver diseases, and other obesity-associated sequelae.